Editorial Contributor

Silvio Inzucchi, MD

Endocrinologist
A native New Yorker, Dr. Inzucchi received his undergraduate degree from Fordham University in the Bronx and his M.D. degree from Harvard Medical School in Boston. He completed his residency in Internal Medicine and his post-doctoral Fellowship in Endocrinology and Metabolism at Yale-New Haven Hospital, in New Haven, CT. He is currently Professor of Medicine at the Yale University School of Medicine in New Haven, where he serves as Clinical Director of the Section of Endocrinology and Program Director of the Endocrinology & Metabolism Fellowship. He is also directs the Yale Diabetes Center at Yale-New Haven Hospital.


Dr. Inzucchi has been an invited lecturer both nationally and internationally on many topics, most pertaining to clinical diabetes management. He has authored or co-authored more than 300 manuscripts, chapters, and abstracts, some published in the foremost medical journals, including the New England Journal of Medicine and JAMA. A former member of the editorial board of Diabetes Care, Dr. Inzucchi is currently an Associate Editor of the Journal of Clinical Endocrinology and Metabolism.  Dr. Inzucchi co-chaired the writing group for the recent ADA-EASD Position Statement on Antihyperglcyemic Therapy in Type 2 Diabetes.

His current research interests include diagnostic criteria for diabetes; the link between type 2 diabetes, insulin resistance, and cardiovascular complications; the evaluation of the asymptomatic diabetic patient for coronary artery disease; and the inpatient management of hyperglycemia.

Dr. Inzucchi also has a large academic clinical practice involving a wide spectrum of patients with endocrine and metabolic conditions.